Lv3
360 积分 2024-01-25 加入
Alectinib versus Crizotinib in Untreated ALK-Positive Non–Small-Cell Lung Cancer
8小时前
待确认
Alectinib versus crizotinib in untreated Asian patients with anaplastic lymphoma kinase-positive non-small-cell lung cancer (ALESIA): a randomised phase 3 study
8小时前
已完结
[Application of augmented reality navigation in laparoscopic and robot-assisted liver surgery]
1个月前
已完结
Targeting HER2 in non-small-cell lung cancer (NSCLC): a glimpse of hope? An updated review on therapeutic strategies in NSCLC harbouring HER2 alterations
2个月前
已完结
Trastuzumab Deruxtecan in HER2-Mutant Non-Small-Cell Lung Cancer
2个月前
已完结
The STAT3-Binding Long Noncoding RNA lnc-DC Controls Human Dendritic Cell Differentiation
2个月前
已完结
Efficacy and Safety of Taletrectinib in Chinese Patients With ROS1+ Non–Small Cell Lung Cancer: The Phase II TRUST-I Study
3个月前
已完结
The changing treatment landscape of EGFR-mutant non-small-cell lung cancer
3个月前
已完结
STK11 and KEAP1 mutations in non-small cell lung cancer patients: Descriptive analysis and prognostic value among Hispanics (STRIKE registry-CLICaP)
7个月前
已完结
The evolutionary theory of cancer: challenges and potential solutions
7个月前
已完结
皖公网安备34019202002308
